The FTC asked that 'pharma bro' Martin Shkreli be held in contempt for failing to comply with an investigation into whether he violated his ban from the pharmaceuticals industry
The Federal Trade Commission on Friday asked that “pharma bro” Martin Shkreli be held in contempt for failing to comply with an investigation into whether he violated a court order banning him from the pharmaceutical industry.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
‘Pharma bro’ Martin Shkreli yet to pay $65M fine for lifetime ban: FTCThe FTC said the “pharma bro” pay hasn’t paid any of a $64.6 million penalty that accompanied the ban.
Leer más »
FTC Alleges Martin 'Pharma Bro' Shkreli Is Trying to Break Back Into Pharma IndustryA federal judge previously barred the former CEO of Vyera Pharmaceutical from in any way working with or in the pharma industry again.
Leer más »
FTC calls on federal court to hold 'pharma bro' Martin Shkreli in contempt | CNN BusinessThe Federal Trade Commission on Friday called for a federal court to hold 'Pharma Bro' Martin Shkreli in contempt after Shkreli allegedly flouted a recent FTC investigation into his business dealings and failed to make a $64.6 million payment he owed for his prior wrongdoings.
Leer más »
Feds Wants ‘Pharma Bro’ Martin Shkreli Held in ContemptAuthorities say Shkreli hasn’t paid a $64.6 million judgment and may be violating a court order barring him from the pharmaceutical business.
Leer más »
FTC calls for Martin Shkreli to be held in contempt of court for forming new drug companyThe FTC on Friday asked that Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge’s ban on the convicted fraudster from working in the pharmaceuticals industry.
Leer más »
FTC Asks Judge to Hold ‘Pharma Bro' Martin Shkreli in Contempt of Court for Forming New Drug FirmThe FTC asked that notorious 'pharma bro' Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge's ban on the convicted fraudster from working in the pharmaceuticals industry.
Leer más »